Literature DB >> 23988500

Association between 5-HT2A receptor polymorphisms and risk of obstructive sleep apnea and hypopnea syndrome: a systematic review and meta-analysis.

Yanhui Zhao1, Li Tao, Ping Nie, Xiaofeng Lu, Xiaolong Xu, Jindong Chen, Min Zhu.   

Abstract

Obstructive sleep apnea and hypopnea syndrome (OSAHS) is a common disorder with several predisposing factors, which may include genetic causes. Studies of the association of susceptibility to and severity of OSAHS with the polymorphisms of the 5-HTR 2A/2C genes have had low statistical power and have yielded inconsistent results. To clarify the association we perform a meta-analysis that combines the genotyping data from all eligible published studies. We quantitatively analyzed five publications, which included a pool of 633 cases and 512 controls, addressing the 5-HT receptor polymorphism and the risk of OSAHS. Hardy-Weinberg equilibrium (HWE) and the minor allele frequency of genetic frequency distributions for the controls were calculated. Differences in the distribution of genotypes between cases and controls were compared by odds ratios (ORs) with their 95% confidence intervals (CIs). For each genetic model, data were pooled using fixed- or random-effects models, depending on the inter-publication heterogeneity. Our results from pooled data showed that individuals carrying the 5-HTR 2A -1438G/A AA genotype had an increased risk of OSAHS (OR=3.69, 95% CI=1.92-7.08) compared with those carrying the GG genotype. Significant results were also reached under a recessive model (OR=3.16, 95% CI=2.33-4.30, p<0.01). However, the results declined to an OR of 2.16 (95% CI=0.9-5.21) in a homozygote model when the studies were restricted to HWE. No statistically significant results concerning an association of the 102C/T polymorphism of the 5-HTR 2A gene with OSAHS were reached (p>0.05 for each genetic model). This meta-analysis suggested that the 5-HTR 2A -1438G/A genotype might modulate an elevated risk of OSAHS. No association of the 5-HTR 2A 102C/T genotype polymorphism with OSAHS was established. However, some publications exhibited HWE bias, which might influence the reliability of pooled data. Further studies in this field, using larger samples, better designs and additional ethnicities, are warranted. Crown
Copyright © 2013. All rights reserved.

Entities:  

Keywords:  5-HT; 5-Hydroxytryptamine receptor; 5-hydroxytryptamine; AHI; BMI; CI; HWE; Hardy–Weinberg equilibrium; Meta-analysis; OR; OSAHS; Obstructive sleep apnea and hypopnea syndrome; Polymorphism; apnea–hypopnea index; body mass index; confidence interval; obstructive sleep apnea and hypopnea syndrome; odds ratio

Mesh:

Substances:

Year:  2013        PMID: 23988500     DOI: 10.1016/j.gene.2013.08.012

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Variants in angiopoietin-2 (ANGPT2) contribute to variation in nocturnal oxyhaemoglobin saturation level.

Authors:  Heming Wang; Brian E Cade; Han Chen; Kevin J Gleason; Richa Saxena; Tao Feng; Emma K Larkin; Ramachandran S Vasan; Honghuang Lin; Sanjay R Patel; Russell P Tracy; Yongmei Liu; Daniel J Gottlieb; Jennifer E Below; Craig L Hanis; Lauren E Petty; Shamil R Sunyaev; Alexis C Frazier-Wood; Jerome I Rotter; Wendy Post; Xihong Lin; Susan Redline; Xiaofeng Zhu
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

2.  5-HTR2A and IL-6 polymorphisms and obstructive sleep apnea-hypopnea syndrome.

Authors:  Wenjuan Wu; Zhijun Li; Tingyu Tang; Jinyan Wu; Fang Liu; Liang Gu
Journal:  Biomed Rep       Date:  2015-12-16

3.  Obstructive sleep apnea syndrome susceptible genes in the Chinese population: a meta-analysis of 21 case-control studies.

Authors:  Fen Lan; Chao Cao; Jinkai Liu; Wen Li
Journal:  Sleep Breath       Date:  2015-04-28       Impact factor: 2.816

4.  Oral appliance effectively reverses Muller's maneuver-induced upper airway collapsibility in obstructive sleep apnea and hypopnea syndrome.

Authors:  Yanhui Zhao; Huimin Shi; Xiaofeng Lu; Jindong Chen; Ping Nie; Yanmei Tang; Li Tao; Min Zhu
Journal:  Sleep Breath       Date:  2014-05-29       Impact factor: 2.816

5.  Whole Genome DNA Methylation Analysis of Obstructive Sleep Apnea: IL1R2, NPR2, AR, SP140 Methylation and Clinical Phenotype.

Authors:  Yung-Che Chen; Ting-Wen Chen; Mao-Chang Su; Chung-Jen Chen; Kuang-Den Chen; Chia-Wei Liou; Petrus Tang; Ting-Ya Wang; Jen-Chieh Chang; Chin-Chou Wang; Hsin-Ching Lin; Chien-Hung Chin; Kuo-Tung Huang; Meng-Chih Lin; Chang-Chun Hsiao
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

6.  Nutrigenetic genotyping study in relation to Sleep Apnea Clinical Score.

Authors:  K Gkouskou; I M Vlastos; D Chaniotis; A Markaki; K Choulakis; E Prokopakis
Journal:  Sleep Breath       Date:  2018-10-17       Impact factor: 2.816

7.  Comparisons of thyroid hormone, intelligence, attention, and quality of life in children with obstructive sleep apnea hypopnea syndrome before and after endoscopic adenoidectomy.

Authors:  Hui-Wei Feng; Tao Jiang; Hong-Ping Zhang; Zhe Wang; Hai-Ling Zhang; Hui Zhang; Xue-Mei Chen; Xian-Liang Fan; Yu-Dong Tian; Tao Jia
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

8.  Relationship between Job Stress and 5-HT2A Receptor Polymorphisms on Self-Reported Sleep Quality in Physicians in Urumqi (Xinjiang, China): A Cross-Sectional Study.

Authors:  Xiaoyan Gao; Hua Ge; Yu Jiang; Yulong Lian; Chen Zhang; Jiwen Liu
Journal:  Int J Environ Res Public Health       Date:  2018-05-21       Impact factor: 3.390

9.  Pharmacodynamic Gene Testing in Prader-Willi Syndrome.

Authors:  Janice Forster; Jessica Duis; Merlin G Butler
Journal:  Front Genet       Date:  2020-11-20       Impact factor: 4.599

Review 10.  A systematic review and meta-analysis of the association between serotonergic gene polymorphisms and obstructive sleep apnea syndrome.

Authors:  Huajun Xu; Jian Guan; Hongliang Yi; Shankai Yin
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.